Shelly Rae Rich is a freelance writer specializing in health and medical research. She holds a B.S. in Chemistry and worked as a laboratory technician at Washington University Medical School studying immunological characteristics of ulcerative colitis and Crohn's disease.
AdAlta biotech announced that its lead drug candidate, AD-114, reduced fibrosis in both the liver and lungs of mice with fibrotic conditions. AD-114 is a novel first-in-class drug candidate called ... Read more
A University of Vermont medical professor has won a $6.3 million award to study antioxidant therapy as a possible treatment option for those with lung diseases such as pulmonary fibrosis ... Read more
Pin It on Pinterest